Canadian contract services company MDS Pharma Services reported disappointing results in its fiscal fourth quarter, with revenues dropping 9 per cent to $112m.
French chemicals company Rhodia has effectively written off the
value of its troubled Rhodia Pharma Solutions division in its
second quarter accounts, giving it a book value of zero.